The application process for expanded access involves several steps:
The treating physician must contact the manufacturer of the investigational drug to obtain its agreement to provide the drug. A formal request must be submitted to the FDA by the treating physician, including detailed information about the patient's medical history and the rationale for requesting the investigational therapy. An Institutional Review Board (IRB) must review and approve the expanded access request to ensure patient safety.
